NeuroBo Pharmaceuticals Inc (NRBO)
3.10
+0.08
(+2.65%)
USD |
NASDAQ |
Apr 24, 16:00
3.10
0.00 (0.00%)
Pre-Market: 09:11
NeuroBo Pharmaceuticals Price to Book Value: 0.9115 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 0.9115 |
| April 23, 2024 | 0.888 |
| April 22, 2024 | 0.9174 |
| April 19, 2024 | 0.9909 |
| April 18, 2024 | 1.012 |
| April 17, 2024 | 1.017 |
| April 16, 2024 | 0.9997 |
| April 15, 2024 | 1.038 |
| April 12, 2024 | 1.062 |
| April 11, 2024 | 1.053 |
| April 10, 2024 | 1.047 |
| April 09, 2024 | 1.038 |
| April 08, 2024 | 1.167 |
| April 05, 2024 | 1.141 |
| April 04, 2024 | 1.144 |
| April 03, 2024 | 1.144 |
| April 02, 2024 | 1.156 |
| April 01, 2024 | 1.194 |
| March 28, 2024 | 1.203 |
| March 27, 2024 | 1.276 |
| March 26, 2024 | 1.264 |
| March 25, 2024 | 1.289 |
| March 22, 2024 | 1.311 |
| March 21, 2024 | 1.347 |
| March 20, 2024 | 1.291 |
| Date | Value |
|---|---|
| March 19, 2024 | 1.208 |
| March 18, 2024 | 1.276 |
| March 15, 2024 | 1.353 |
| March 14, 2024 | 1.338 |
| March 13, 2024 | 1.314 |
| March 12, 2024 | 1.432 |
| March 11, 2024 | 1.506 |
| March 08, 2024 | 1.576 |
| March 07, 2024 | 1.605 |
| March 06, 2024 | 1.650 |
| March 05, 2024 | 1.850 |
| March 04, 2024 | 1.917 |
| March 01, 2024 | 1.835 |
| February 29, 2024 | 1.702 |
| February 28, 2024 | 1.506 |
| February 27, 2024 | 1.414 |
| February 26, 2024 | 1.644 |
| February 23, 2024 | 1.558 |
| February 22, 2024 | 1.686 |
| February 21, 2024 | 1.711 |
| February 20, 2024 | 1.573 |
| February 16, 2024 | 1.550 |
| February 15, 2024 | 1.420 |
| February 14, 2024 | 1.403 |
| February 13, 2024 | 1.450 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3233
Minimum
Nov 07 2022
59.61
Maximum
Apr 13 2020
6.206
Average
3.012
Median
May 29 2019
Price to Book Value Benchmarks
| Conmed Corp | 2.583 |
| Eli Lilly and Co | 64.63 |
| Vanda Pharmaceuticals Inc | 0.4815 |
| Alaunos Therapeutics Inc | 2.996 |
| Relmada Therapeutics Inc | 1.364 |
Price to Book Value Related Metrics
| Price | 3.10 |
| Earnings Yield | -76.77% |
| Market Cap | 15.21M |